Search
for
Sort by
Research 30 of 130
- Progesterone-induced stimulation of mammary tumorigenesis is due to the progesterone metabolite, 5α-dihydroprogesterone (5αP) and can be suppressed by the 5α-reductase inhibitor, finasteride
- The neurosteroid metabolite of progesterone, 3α‐OH‐dihydroprogesterone (3α‐OH‐DHP), is required for attenuated baroreflex mediated sympathoexcitation in pregnancy
- Possible involvement of 5α-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells
- Exploring the Impact of the Microbiome on Neuroactive Steroid Levels in Germ-Free Animals
- Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain
- Sexually dimorphic effect of progesterone and its reduced metabolites on the gene expression of myelin proteins in rat Schwann cells
- Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Roles of Type 10 17beta-Hydroxysteroid Dehydrogenase in Intracrinology and Metabolism of Isoleucine and Fatty Acids
- Biology and Detection of Pregnanes During Late Gestation in the Mare
- Progesterone and its Metabolites: Anticonvulsant and Behavioral Studies
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- The anticonvulsant effects of progesterone and its metabolites
- Effect of finasteride on the ovulatory function of normal women
- Studies on Neurosteroids XXV. Influence of a 5.ALPHA.-Reductase Inhibitor, Finasteride, on Rat Brain Neurosteroid Levels and Metabolism
- 5α-Reduced glucocorticoids: a story of natural selection
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Post-finasteride syndrome: An emerging clinical problem
- Finasteride-induced depression: new insights into possible pathomechanisms
- Is there a role for 5α‐reductase inhibitors in transgender individuals?
- Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia
- Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABA<sub>A</sub>Receptor Function and Seizure Susceptibility
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Finasteride Blocks the Reduction in Ictal Activity Produced by Exogenous Estrous Cyclicity
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review